Casdin Capital’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.4M | Hold |
1,295,361
| – | – | 1.76% | 12 |
|
|
2025
Q1 | $15.2M | Hold |
1,295,361
| – | – | 1.24% | 15 |
|
|
2024
Q4 | $29.6M | Buy |
1,295,361
+770,745
| +147% | +$17.6M | 1.97% | 13 |
|
|
2024
Q3 | $22M | Hold |
524,616
| – | – | 1.47% | 17 |
|
|
2024
Q2 | $19.1M | Hold |
524,616
| – | – | 1.46% | 16 |
|
|
2024
Q1 | $26.7M | Hold |
524,616
| – | – | 1.99% | 16 |
|
|
2023
Q4 | $10.2M | Buy |
+524,616
| New | +$10.2M | 1% | 22 |
|